Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.

NCT01258374 · clinicaltrials.gov ↗

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Integrase Inhibitors, HIV; HIV PROTEASE INHIB

Interventions

DRUG: Raltegravir
DRUG: Darunavir

Sponsor

Hospital Clinic of Barcelona